22
Please see the Informed Consent Form for complete details. TEST. JOIN. RISE ABOVE. THE ACTIV-2 STUDY: REVIEW OF THE INFORMED CONSENT FORM

THE ACTIV-2 STUDY:REVIEW OF CONSENT FORM THE INFORMED · 2020. 12. 26. · THE ACTIV-2 STDY! 1 •elcome to the ACTIV-2 Study! W • You have been asked to take part in the ACTIV-2

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Please see the Informed Consent Form for complete details.

    TEST. JOIN. RISE ABOVE.

    THE ACTIV-2 STU

    DY:

    REVIEW OF

    THE INFORMED

    CONSENT FORM

  • Please see the Informed Consent Form for complete details.

    THE ACTIV-2 STU

    DY:

    REVIEW OF

    THE INFORMED

    CONSENT FORM

    TEST. JOIN. RISE ABOVE.

  • The ACTIV-2 Study is testing different medicines for adults with COVID-19.

    Today we’ll review:• Why we are doing this study• What to expect during the study• Some potential risks and benefits

    Being in the study is your choice!

    Ask questions!

    WELCOME TO

    THE ACTIV-2

    STUDY!

    1

    • Welcome to the ACTIV-2 Study!

    • You have been asked to take part in theACTIV-2 Study because you have beendiagnosed with COVID-19.

    • The ACTIV-2 Study is testing differentmedicines to see if they are safe and can helpadults with COVID-19.

    • We will go over some important parts fromthe informed consent form. You will be givena few different consent forms, but for now wewill discuss the main informed consent form.This paperwork contains all of the informationabout the study, including the purpose of thestudy, visits and tests, and possible benefitsand risks.

    • Today we’ll review:• Why we are doing this study• What to expect during the study• Some potential risks and benefits

    • Being in the study is your choice.

    • If you decide to join, your personal informationwill be kept private.

    • Ask any questions you may have.

    Before we go over what a clinical study is, do you have any questions about what we’re going to talk about today?

    DISCUSSION QUESTION

    Welcome

    1

  • The ACTIV-2 Study is testing different medicines for adults with COVID-19.

    Today we’ll review:• Why we are doing this study• What to expect during the study• Some potential risks and benefits

    Being in the study is your choice!

    Ask questions!

    WELCOME TO

    THE ACTIV-2

    STUDY!

    1

  • • A clinical study, or research study, is done tolearn more about what a new medicine doesinside the body.

    • Every medicine that you have ever taken hasbeen tested in a clinical study.

    • Studies are important because they see whatkind of side effects a medicine may have and ifit can help the people who need it.

    Before we talk about the ACTIV-2 Study, do you have any questions about clinical studies in general?

    DISCUSSION QUESTION

    What is a clinical study?

    A clinical study is a research study to learn more about what a medicine does inside the body.

    • Are there side effects?

    • Can it help people?

    WHAT IS A

    CLINICAL

    STUDY?

    2

    2

  • A clinical study is a research study to learn more about what a medicine does inside the body.

    • Are there side effects?

    • Can it help people?

    WHAT IS A

    CLINICAL

    STUDY?

    2

  • Researchers want to see which medicines:

    WHY IS THE

    ACTIV-2 STUDY

    BEING DONE?

    Can prevent people from having to go

    to the hospital

    Can get rid of the virus

    Can help people get

    better faster

    Can keep people from getting sicker

    Are safe for those who need them

    Can help keep oxygen

    levels up

    3

    • Right now there is no medicine proven to treatCOVID-19 in people who are not sick enoughto be hospitalized.

    • Researchers will be testing different medicinesthat they believe are most likely to help peoplewith COVID-19.

    • They want to see if these medicines:• Are safe for those who need them• Can help people get better faster• Can get rid of the virus• Can help keep oxygen levels up• Can keep people from getting sicker• Can prevent people from having to go to the

    hospital

    Do you have any questions about why this study is being done?

    DISCUSSION QUESTION

    Why is the ACTIV-2 Study being done?

    3

  • Researchers want to see which medicines:

    WHY IS THE

    ACTIV-2 STUDY

    BEING DONE?

    Can prevent people from having to go

    to the hospital

    Can get rid of the virus

    Can help people get

    better faster

    Can keep people from getting sicker

    Are safe for those who need them

    Can help keep oxygen

    levels up

    3

  • WHAT

    HAPPENS

    DURING THE

    STUDY? Have in-person visits with tests and health checks.

    Have phone calls or video chats with the researcher.

    Fill out your study diary.

    The study lasts 6 months. During this time you will:

    4

    • The whole study lasts about 6 months (24 weeks).

    • During the study you would have in-personvisits with tests to check on your health. Mostof these visits happen during the first month ofthe study.

    • You would also have phone calls or videos chatswith the researcher from your home.

    • The study team will give you a diary to keeptrack of your temperature each evening andany symptoms you have. You’ll be asked to fillout this diary for the first 28 days.

    Do you have any questions about what happens during the study in general?

    DISCUSSION QUESTION

    What happens during the study?

    4

  • WHAT

    HAPPENS

    DURING THE

    STUDY? Have in-person visits with tests and health checks.

    Have phone calls or video chats with the researcher.

    Fill out your study diary.

    The study lasts 6 months. During this time you will:

    4

  • WHAT

    HAPPENS

    FIRST??

    • Give your permission by signing the informed consent form.

    • Screening: Answer questions to make sure the study is right for you.

    5

    • Before you decide whether to take part, readthe main informed consent form and ask anyquestions that you may have.

    • If you agree to be in the study, you will giveyour permission by signing the informedconsent form. Make sure you understand andagree to the study before signing.

    • For each medicine being tested, there may be2 parts to the study, called Phase 2 and Phase3. If you agree to join the study, you would betold which phase is open for you to join.

    • During the screening process, the study teamwill ask you questions in person, over thephone, or by video chat to make sure the studyis right for you.• They will ask you questions about your

    current and past health, any medicines youtake or have taken in the past, and yoursymptoms of COVID-19.

    • If you meet with the researcher in person,you may also have a checkup.

    Do you have any questions about the informed consent form and giving your consent?

    Do you have any questions about the screening process?

    DISCUSSION QUESTIONS

    What happens first?

    5

  • WHAT

    HAPPENS

    FIRST??

    • Give your permission by signing the informed consent form.

    • Screening: Answer questions to make sure the study is right for you.

    5

  • WHAT

    TREATMENT

    MIGHT

    I GET?

    Each study medicine will be compared to a placebo.

    Different medicines may be tested during the study at the same time.

    6

    • If the study is right for you, you will have your firstvisit, or entry visit, to meet with a researcher fortests and to be placed in a treatment group.

    • Each study medicine will be compared to aplacebo. A placebo looks like the real drug butdoesn’t have any actual medicine in it. This givesresearchers something to compare the studymedicine to.• You would not know if you are receiving the

    study medicine or placebo until the end of thestudy.

    • If a standard treatment for COVID-19 is foundduring the study, that treatment will be usedinstead of placebo.

    • Different medicines may be tested during thestudy at the same time.• One type of medicine you might receive is

    called a monoclonal antibody. Antibodies arenaturally made by your body to help fightdisease. Monoclonal antibodies are made in thelab and help your body attack invaders, such asviruses, to keep them from entering your cells.

    • Once you are placed in a treatment group, you willreceive more information on that medicine beingtested, including any possible side effects.

    Do you have any questions in general about the treatment groups?

    DISCUSSION QUESTION

    What treatment might I get?

    6

  • WHAT

    TREATMENT

    MIGHT

    I GET?

    Each study medicine will be compared to a placebo.

    Different medicines may be tested during the study at the same time.

    6

  • Pills A shot or injection

    An infusion

    HOW MIGHT

    I TAKE THE

    STUDY

    MEDICINE?

    Medicines come in all different forms:

    7

    • Medicines come in all different forms:• Pills taken by mouth• A shot or injection• An infusion, which is given slowly through a

    needle into a vein

    • After you are put in a treatment group, theresearcher will give you more information abouthow that study medicine or placebo is given.

    Do you have any questions about the different ways the study medicine may be given?

    DISCUSSION QUESTION

    How might I take the study medicine?

    7

  • Pills A shot or injection

    An infusion

    HOW MIGHT

    I TAKE THE

    STUDY

    MEDICINE?

    Medicines come in all different forms:

    7

  • Tests and health checks

    Heart rate

    Nose swab

    Blood pressure

    Blood test

    Checkup

    Oxygen levels

    Saliva test

    Deep nose swab

    WeightTemperature

    WHAT

    HAPPENS

    AT STUDY

    VISITS?

    Phase 2: 7 visits2 phone calls

    Phase 3: 3 visits5 phone calls

    8

    • You will have up to 7 visits with a researcherfor tests and up to 5 phone calls at home withthe researcher or nurse. The number of visitsor phone calls depends on whether you are inPhase 2 or Phase 3 of the study.

    • At the visits, you will have tests and healthchecks to see how you are doing. You won’thave all of these tests at each visit.

    • You will do your own nose swabs at visits and athome. The study team will teach you how to dothem. You will be asked to write in your studydiary when you do the swabs.

    Do you have any questions about the tests you would have?

    DISCUSSION QUESTION

    What happens at study visits?

    8

  • Tests and health checks

    Heart rate

    Nose swab

    Blood pressure

    Blood test

    Checkup

    Oxygen levels

    Saliva test

    Deep nose swab

    WeightTemperature

    WHAT

    HAPPENS

    AT STUDY

    VISITS?

    Phase 2: 7 visits2 phone calls

    Phase 3: 3 visits5 phone calls

    8

  • ?WHAT

    ARE THE

    RISKS AND

    BENEFITS?

    The study medicine may or may not make you better.

    There is a chance for side effects with the study medicine. Monoclonal antibodies, for example, can cause allergic reactions and symptoms such as fever, chills, nausea, headache, wheezing, throat irritation, rash, itch, and dizziness.

    Information learned from this study may help others who have COVID-19.

    9

    • There are risks to taking part in any clinicalstudy.• It is not known if the study medicine will work.• The study medicine may not stop you from

    becoming sicker or being hospitalized.• Like with all medicine, there is also a chance

    for side effects. Tell the study team rightaway if you don’t feel well.

    • You may or may not have a direct benefit frombeing in the study. But information learnedfrom this study may help others who haveCOVID-19 in the future.

    • The informed consent form has moreinformation about possible risks and benefitsof being in the study. Ask the study team anyquestions you may have.Do you have any questions about the

    possible risks and benefits of being in the study?

    DISCUSSION QUESTION

    What are the risks and benefits?

    9

  • ?WHAT

    ARE THE

    RISKS AND

    BENEFITS?

    The study medicine may or may not make you better.

    There is a chance for side effects with the study medicine. Monoclonal antibodies, for example, can cause allergic reactions and symptoms such as fever, chills, nausea, headache, wheezing, throat irritation, rash, itch, and dizziness.

    Information learned from this study may help others who have COVID-19.

    9

  • ACTIV-2 Study -Informed Consent - 08-Sep-2020 - V1.0

    WHAT

    HAPPENS

    NEXT?

    THANK YOU!

    Read the informed consent forms.

    Ask questions.

    Being in the study is your choice!

    • Read the informed consent form and think it over.

    • Ask any questions you have about this study atany time.

    • Being in the study is your choice. If you joinand then change your mind, you can stop atany time.

    • If you decide to join, you would sign theinformed consent form.

    • Thank you for your time and for consideringtaking part in the ACTIV-2 Study.

    Do you have any other questions about this study?

    DISCUSSION QUESTION

    What happens next?

    10

  • ACTIV-2 Study -Informed Consent -11-Sep-2020 - V1.0

    WHAT

    HAPPENS

    NEXT?

    THANK YOU!

    Read the informed consent forms.

    Ask questions.

    Being in the study is your choice!